These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3967153)

  • 1. [The importance of apolipoprotein B determination in familial hyperlipoproteinemia].
    Oravec S; Raslová K; Kolesár P; Lukácová M
    Bratisl Lek Listy; 1985 Jan; 83(1):80-6. PubMed ID: 3967153
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in apolipoprotein B concentrations in various types of lipid metabolism disorders].
    Bobilewicz D; Kotlicka J; Drewnowska I
    Pol Tyg Lek; 1983 Sep; 38(36):1097-100. PubMed ID: 6674938
    [No Abstract]   [Full Text] [Related]  

  • 3. [Apolipoproteins A-1 and B of the blood plasma and apolipoproteins A-1 of 2 high-density lipoprotein subclasses in ischemic heart disease patients with various lipoprotein spectra].
    Metel'skaia VA; Perova NV; Chernysheva NP; Kurdanov KhA; Polesskiĭ VA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(1):83-9. PubMed ID: 6407489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease.
    Zambon A; Brown BG; Deeb SS; Brunzell JD
    J Intern Med; 2006 May; 259(5):473-80. PubMed ID: 16629853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic heterogeneity in very low-density lipoproteins.
    Shepherd J; Packard CJ
    Am Heart J; 1987 Feb; 113(2 Pt 2):503-8. PubMed ID: 3812208
    [No Abstract]   [Full Text] [Related]  

  • 6. Laboratory-based assessment of plasma lipids and lipoproteins for the classification of familial hypercholesterolemic and hypertriglyceridemic states.
    Demacker PN
    Semin Vasc Med; 2004 Feb; 4(1):13-22. PubMed ID: 15199429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum lipids and smoking habit in first degree relatives of patients of ischaemic heart disease.
    Vajpayee A; Chadda VS; Jain NC; Mishra SN; Sulemani AA; Singhvi DR
    Indian Heart J; 1981; 33(6):274-6. PubMed ID: 7341399
    [No Abstract]   [Full Text] [Related]  

  • 8. Early and late results of coronary artery bypass in patients with hyperlipoproteinemia.
    Hanson EC; Levine FH; Adzick NS; Lees RS; Daggett WM; Austen WG; Buckley MJ
    J Thorac Cardiovasc Surg; 1980 Mar; 79(3):372-80. PubMed ID: 6965512
    [No Abstract]   [Full Text] [Related]  

  • 9. [Application of the immunoenzyme technic in double determination of antibodies for the study of hyperlipoproteinemia].
    Kandoussi A; Cachera C; Reade R; Tacquet A; Fruchart JC
    Ann Biol Clin (Paris); 1990; 48(6):365-8. PubMed ID: 2221495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of familial defective apolipoprotein B-100 in Japanese patients with familial hypercholesterolaemia.
    Nohara A; Yagi K; Inazu A; Kajinami K; Koizumi J; Mabuchi H
    Lancet; 1995 Jun; 345(8962):1438. PubMed ID: 7760626
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices].
    Herrmann W; Reuter W
    Z Gesamte Inn Med; 1982 Dec; 37(24):830-3. PubMed ID: 6963524
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo platelet activity and lipoprotein patterns in coronary artery disease.
    Goubran F; Maklady F; Saad M; el-Ashry M
    Wien Klin Wochenschr; 1986 Apr; 98(7):209-11. PubMed ID: 3705598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial defective apolipoprotein B-100: mild hypercholesterolaemia without atherosclerosis in a homozygous patient.
    März W; Ruzicka C; Pohl T; Usadel KH; Gross W
    Lancet; 1992 Nov; 340(8831):1362. PubMed ID: 1360085
    [No Abstract]   [Full Text] [Related]  

  • 14. [Subfractions of HDL cholesterol. Occurrence in hyperlipoproteinemia type IIa and IV].
    Mertz DP; Thuilot G; Bürvenich K
    Fortschr Med; 1986 Jul; 104(26):508-10. PubMed ID: 3744260
    [No Abstract]   [Full Text] [Related]  

  • 15. [Primary hyperlipoproteinemia in its clinical and laboratory aspects. IV. Blood coagulation and fibrinolysis indicators].
    Borodin M; Jurek D; Gregorczyk J; Pieczul-Mróz J; Cwajda H
    Przegl Lek; 1983; 40(10):727-32. PubMed ID: 6665208
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypercholesterolaemia presenting in a patient with familial defective apolipoprotein B-100 and hypothyroidism.
    Wenham PR; Giles PD; Ashby JP
    Ann Clin Biochem; 1995 Mar; 32 ( Pt 2)():221-5. PubMed ID: 7785956
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of oxandrolone on plasma lipoproteins in patients with type IIa, IIb and IV hyperlipoproteinemia: occurrence of hypo-high density lipoproteinemia.
    Tamai T; Nakai T; Yamada S; Kobayashi T; Hayashi T; Kutsumi Y; Takeda R
    Artery; 1979 Feb; 5(2):125-43. PubMed ID: 231951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial defective apolipoprotein B-100: molecular basis, prevalence and clinical features.
    Friedl W
    Wien Klin Wochenschr; 1991; 103(20):621-5. PubMed ID: 1763509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E phenotype frequency in type II diabetic patients with different forms of hyperlipoproteinemia.
    Parhofer KG; Richter WO; Schwandt P
    Horm Metab Res; 1990 Nov; 22(11):589-94. PubMed ID: 2272605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics of hypercholesterolamemia: the detection of mutations in the apolipoprotein B gene using denaturing gradient gel electrophoresis.
    Gaffney D; Reid JM; Vass K; Packard CJ
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():19-20. PubMed ID: 8767449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.